Cure Candidates: Characteristics Of > 10yr Progression-Free Survivors (Pfs-10) And Continuous Cr (Ccr-10) After Total Therapy 1 And 2 (Tt1, Tt2) For Multiple Myeloma (Mm)
JOURNAL OF CLINICAL ONCOLOGY（2013）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要